接受口服双膦酸盐治疗患者的颌骨骨坏死 - Suppr

Suppr

超能文献

Osteonecrosis of the jaw in patients receiving oral bisphosphonates.

作者信息

Kyrgidis Athanassios, Vahtsevanos Konstantinos

出版信息

Osteoporos Int. 2010 Mar;21(3):535-6. doi: 10.1007/s00198-009-1089-5. Epub 2009 Oct 28.

DOI:10.1007/s00198-009-1089-5

PMID:19862464

Abstract

摘要

相似文献

Osteonecrosis of the jaw in patients receiving oral bisphosphonates.

Osteoporos Int. 2010 Mar;21(3):535-6. doi: 10.1007/s00198-009-1089-5. Epub 2009 Oct 28.

Oral bisphosphonates and osteonecrosis of the jaw.

Gen Dent. 2007 Jan-Feb;55(1):8-10.

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00021.

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791-2; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00022.

Osteonecrosis of the jaw in patients taking bisphosphonates.

Joint Bone Spine. 2006 Jan;73(1):7-9. doi: 10.1016/j.jbspin.2005.11.002. Epub 2005 Dec 9.

Osteonecrosis of the jaw and bisphosphonates: editorial was confusing.

BMJ. 2006 Nov 25;333(7578):1122-3. doi: 10.1136/bmj.39037.696759.3A.

Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.

BMJ. 2006 Nov 11;333(7576):982-3. doi: 10.1136/bmj.39024.647558.BE.

Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.

J Mich Dent Assoc. 2005 Nov;87(11):40-2.

Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.

J Okla Dent Assoc. 2008 Apr-May;99(7):28-9.

Bisphosphonates and oral health.

J Esthet Restor Dent. 2008;20(1):74-5. doi: 10.1111/j.1708-8240.2008.00152.x.

引用本文的文献

Intermittent Parathyroid Hormone Injection Can Decrease Femoral Head Collapse in the Vascular Deprivation of Rat Femoral Head Model.

Indian J Orthop. 2019 Mar-Apr;53(2):340-346. doi: 10.4103/ortho.IJOrtho_315_17.

Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws.

Osteoporos Int. 2013 Aug;24(8):2365-9. doi: 10.1007/s00198-013-2277-x. Epub 2013 Jan 31.

Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility.

Ther Clin Risk Manag. 2012;8:253-66. doi: 10.2147/TCRM.S7688. Epub 2012 Jun 11.

Osteonecrosis of jaw associated with bisphosphonate use.

Indian J Endocrinol Metab. 2012 May;16(3):450-2. doi: 10.4103/2230-8210.95711.

Osteoporos Int. 2011 Jan;22(1):369-70. doi: 10.1007/s00198-010-1177-6. Epub 2010 Mar 20.

本文引用的文献

Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

J Clin Oncol. 2009 Nov 10;27(32):5356-62. doi: 10.1200/JCO.2009.21.9584. Epub 2009 Oct 5.

Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1125-34. doi: 10.1586/era.09.74.

Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases.

Osteoporos Int. 2010 Mar;21(3):527-33. doi: 10.1007/s00198-009-0973-3. Epub 2009 May 30.

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):2-12. doi: 10.1016/j.joms.2009.01.009.

Osteonecrosis of the jaw among bisphosphonate users.

Am J Med. 2008 Dec;121(12):e21; author reply e23. doi: 10.1016/j.amjmed.2008.08.013.

Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.

J Clin Oncol. 2008 Oct 1;26(28):4634-8. doi: 10.1200/JCO.2008.16.2768. Epub 2008 Jun 23.

Factors associated with osteonecrosis of the jaw among bisphosphonate users.

Am J Med. 2008 Jun;121(6):475-483.e3. doi: 10.1016/j.amjmed.2008.01.047.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Osteonecrosis of the jaw in patients receiving oral bisphosphonates.

Osteoporos Int. 2010 Mar;21(3):535-6. doi: 10.1007/s00198-009-1089-5. Epub 2009 Oct 28.

Oral bisphosphonates and osteonecrosis of the jaw.

Gen Dent. 2007 Jan-Feb;55(1):8-10.

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00021.

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791-2; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00022.

Osteonecrosis of the jaw in patients taking bisphosphonates.

Joint Bone Spine. 2006 Jan;73(1):7-9. doi: 10.1016/j.jbspin.2005.11.002. Epub 2005 Dec 9.

Osteonecrosis of the jaw and bisphosphonates: editorial was confusing.

BMJ. 2006 Nov 25;333(7578):1122-3. doi: 10.1136/bmj.39037.696759.3A.

Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.

BMJ. 2006 Nov 11;333(7576):982-3. doi: 10.1136/bmj.39024.647558.BE.

Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.

J Mich Dent Assoc. 2005 Nov;87(11):40-2.

Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.

J Okla Dent Assoc. 2008 Apr-May;99(7):28-9.

Bisphosphonates and oral health.

J Esthet Restor Dent. 2008;20(1):74-5. doi: 10.1111/j.1708-8240.2008.00152.x.

引用本文的文献

Intermittent Parathyroid Hormone Injection Can Decrease Femoral Head Collapse in the Vascular Deprivation of Rat Femoral Head Model.

Indian J Orthop. 2019 Mar-Apr;53(2):340-346. doi: 10.4103/ortho.IJOrtho_315_17.

Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws.

Osteoporos Int. 2013 Aug;24(8):2365-9. doi: 10.1007/s00198-013-2277-x. Epub 2013 Jan 31.

Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility.

Ther Clin Risk Manag. 2012;8:253-66. doi: 10.2147/TCRM.S7688. Epub 2012 Jun 11.

Osteonecrosis of jaw associated with bisphosphonate use.

Indian J Endocrinol Metab. 2012 May;16(3):450-2. doi: 10.4103/2230-8210.95711.

Osteoporos Int. 2011 Jan;22(1):369-70. doi: 10.1007/s00198-010-1177-6. Epub 2010 Mar 20.

本文引用的文献

Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

J Clin Oncol. 2009 Nov 10;27(32):5356-62. doi: 10.1200/JCO.2009.21.9584. Epub 2009 Oct 5.

Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1125-34. doi: 10.1586/era.09.74.

Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases.

Osteoporos Int. 2010 Mar;21(3):527-33. doi: 10.1007/s00198-009-0973-3. Epub 2009 May 30.

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):2-12. doi: 10.1016/j.joms.2009.01.009.

Osteonecrosis of the jaw among bisphosphonate users.

Am J Med. 2008 Dec;121(12):e21; author reply e23. doi: 10.1016/j.amjmed.2008.08.013.

Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.

J Clin Oncol. 2008 Oct 1;26(28):4634-8. doi: 10.1200/JCO.2008.16.2768. Epub 2008 Jun 23.

Factors associated with osteonecrosis of the jaw among bisphosphonate users.

Am J Med. 2008 Jun;121(6):475-483.e3. doi: 10.1016/j.amjmed.2008.01.047.